Dr. Maria Alejandra Dempaire, MD

Dr. Dempaire practices at South Florida Doctors Group in Pembroke Pines, Florida.

Dr. Dempaire's NPI, 1932551637, was assigned on July 6, 2016. Dr. Dempaire holds Florida license ME140305.

Dr. Dempaire's primary practice is South Florida Doctors Group, at 18503 Pines Blvd, Pembroke Pines, FL 33029 in Broward County. The practice phone is (954) 442-0784.

Dr. Dempaire's primary practice is South Florida Doctors Group in Pembroke Pines, Florida. Dr. Dempaire is also affiliated with Memorial Hospital West. The medical group on file is South Florida Doctors Group. Dmand AI also links Dr. Dempaire to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dempaire practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dempaire's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dempaire is licensed in Florida.

CMS data shows 122 Medicare services from Dr. Dempaire across 4 procedure codes in 2024, for 24 Medicare patients. Medicare paid $7,240 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Dempaire in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dempaire's median patient age at 53, with 65% women.

In 2024, Dr. Dempaire wrote 1,032 Medicare Part D claims for 110 patients. 86% of them were for generic drugs. CMS names the drug for 614 of them, across 27 drugs with 11 or more claims each, at $39,602 in total drug cost. In 2023, CMS named 518 claims across 23 drugs.

Dr. Dempaire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dempaire as offering telehealth.

CMS Open Payments shows 144 general payments to Dr. Dempaire from 32 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 93% of the total. Eli Lilly and Company paid the most, $293.